what is the criteria for semaglutide Comparative Efficacy and Safety of Once-Weekly Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study) Liraglutide vs Semaglutide: Comparing Weight

Mounjaro (tirzepatide) activates two receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor

No randomized trials No controlled studies No validated imaging or outcome measures Only one very small, biased case series 2

Effect of propionyl-L-carnitine on experimental induced cardiomyopathy in rats

6,10 At baseline, patients had a mean A1C of 8.0%, 71% had CAD, 21% had CeVD, 16% had PAD, and 42% had CKD

Clinical trials have shown that patients taking Zepbound achieved greater average weight loss than those on semaglutide-based therapies, with high-dose participants losing up to 21% of body weightover 18 months